Let us introduce PROMPPT. Click play on the video below.
Improving outcomes for patients using opioid medicines for persistent non-cancer pain
Proactive clinical Review of patients taking Opioid Medicines long-term for persistent Pain led by clinical Pharmacists in primary care Teams
Why are we doing this research?
Persistent pain affects up to half the UK adult population and 10- 14% (around 8 million adults) say the pain causes moderate or severe interference with their life.
What does the research involve?
PROMPPT is a 5-year research programme and launched in March 2019.
Year 1 started with the Q-PROMPPT study that aimed to find out about patients, clinical pharmacists and GPs’ experiences and views.
On the evening of January 30th 2020, 14 stakeholders from primary care (GPs, practice nurses, practice managers, clinical pharmacists), health psychology, addiction and community pain services, and patient representatives met for a third and final time in the intervention development phase of the PROMPPT programme.